B cell immunofocusing and repriming in two HIV-1 Env immunization regimens.
Non-classical CD45RBlo memory B-cells are the majority of circulating antigen-specific B-cells following mRNA vaccination and COVID-19 infection.
Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescents
B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins
Recruitment of plasma cells to the bone marrow in primary and secondary immune reactions
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose